Airway Medix (WAR:AWM) Other Stockholders Equity: zł8.80 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:AWM Airway Medix SA WAR:AWM
19 GF Score
Price zł0.26
! 9 Warning Signs
View Full Analysis

What is Airway Medix Other Stockholders Equity?

Airway Medix WAR:AWM -1.51% 19 Other Stockholders Equity is zł8.80 Mil as of Mar. 2026. GuruFocus rates WAR:AWM with a GF Score™ of 19/100. The stock has 9 warning signs investors should review.

Airway Medix's Other Stockholders Equity for the quarter that ended in Mar. 2026 was zł8.80 Mil.

Airway Medix's quarterly Other Stockholders Equity increased from Sep. 2025 (zł4.98 Mil) to Dec. 2025 (zł8.80 Mil) but then declined from Dec. 2025 (zł8.80 Mil) to Mar. 2026 (zł8.80 Mil).

Airway Medix's annual Other Stockholders Equity declined from Dec. 2023 (zł7.83 Mil) to Dec. 2024 (zł4.17 Mil) but then increased from Dec. 2024 (zł4.17 Mil) to Dec. 2025 (zł8.80 Mil).

Airway Medix Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Airway Medix's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Airway Medix Other Stockholders Equity Chart

Airway Medix Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.10 3.51 7.83 4.17 8.80

Airway Medix Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.17 4.17 4.98 8.80 8.80
WAR:AWM
19GF Score
Airway Medix SA WAR:AWM
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Airway Medix Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of zł8.80 Mil mean?
Airway Medix (WAR:AWM) has a Other Stockholders Equity of zł8.80 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Airway Medix and its competitors.
Is Airway Medix's Other Stockholders Equity too high?
Airway Medix's current Other Stockholders Equity is zł8.80 Mil. Overall, Airway Medix has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Airway Medix's Other Stockholders Equity compare to ISRG and BDX?
Airway Medix's Other Stockholders Equity of zł8.80 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Airway Medix and its competitors. Airway Medix's current Other Stockholders Equity is zł8.80 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Airway Medix stock overvalued right now?
Airway Medix (WAR:AWM) has a current Other Stockholders Equity of zł8.80 Mil. The current Other Stockholders Equity is zł8.80 Mil. Airway Medix's overall GF Score™ is 19/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Airway Medix (WAR:AWM), the current Other Stockholders Equity is zł8.80 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Airway Medix Business Description

Other Exchanges D1C:Germany
Address ul. Szara 10, Warszawa, POL, 00-420
Airway Medix SA focuses on research, development, and commercialization of devices for single use in mechanically ventilated patients at Intensive Care Units as well as in patients with life-threatening and anaesthesiologic wards. The company's products include the Closed Suction System, the Oral Care System, and the Cuff Pressure Regulator.
19GF Score

Get the complete analysis for WAR:AWM

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł0.26
Price